FSBCX
Price
$19.98
Change
-$0.17 (-0.84%)
Updated
Feb 21 closing price
Net Assets
277.07M
RIRBX
Price
$72.48
Change
-$0.25 (-0.34%)
Updated
Feb 21 closing price
Net Assets
110.16B
Ad is loading...

FSBCX vs RIRBX

Header iconFSBCX vs RIRBX Comparison
Open Charts FSBCX vs RIRBXBanner chart's image
Federated Hermes Global Allocation C
Price$19.98
Change-$0.17 (-0.84%)
VolumeN/A
Net Assets277.07M
American Funds Capital Income Bldr R2
Price$72.48
Change-$0.25 (-0.34%)
VolumeN/A
Net Assets110.16B
FSBCX vs RIRBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FSBCX vs. RIRBX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSBCX is a StrongBuy and RIRBX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RIRBX has more cash in the bank: 110B vs. FSBCX (277M). RIRBX pays higher dividends than FSBCX: RIRBX (2.55) vs FSBCX (0.83). FSBCX was incepted earlier than RIRBX: FSBCX (32 years) vs RIRBX (23 years). RIRBX is a more actively managed with annual turnover of: 106.00 vs. FSBCX (98.00). RIRBX has a lower initial minimum investment than FSBCX: RIRBX (250) vs FSBCX (1500). RIRBX annual gain was more profitable for investors over the last year : 11.30 vs. FSBCX (9.19). RIRBX return over 5 years is better than : 24.48 vs. FSBCX (6.25).
FSBCXRIRBXFSBCX / RIRBX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence32 years23 years-
Gain YTD2.9374.98359%
Front LoadN/AN/A-
Min. Initial Investment1500250600%
Min. Initial Investment IRAN/AN/A-
Net Assets277M110B0%
Annual Yield % from dividends0.832.5533%
Returns for 1 year9.1911.3081%
Returns for 3 years9.3211.9378%
Returns for 5 years6.2524.4826%
Returns for 10 years15.7631.5450%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KELYA13.870.18
+1.31%
Kelly Services
LRMR3.19-0.08
-2.45%
Larimar Therapeutics
EXPE196.81-8.33
-4.06%
Expedia Group
OSIS202.27-12.10
-5.64%
OSI Systems
SABS1.82-0.13
-6.67%
SAB Biotherapeutics